Literature DB >> 19509568

Parity and time interval since childbirth influence survival in endometrial cancer patients.

Grethe Albrektsen1, Ivar Heuch, Elisabeth Wik, Helga B Salvesen.   

Abstract

Parity and time interval since last birth have been found to be associated with the risk of endometrial cancer, but few previous studies have examined whether these reproductive factors have prognostic impact. We examined this issue among 740 nulliparous and 3355 parous endometrial cancer patients diagnosed in Norway during the period 1961-1999. The mean age at diagnosis was 55.7 years (range, 25-74 years). Hazard ratios (HRs) with 95% confidence intervals were calculated in Cox proportional regression models. Parous women had significantly (P < 0.001) better prognosis than nulliparous women. In analyses adjusted for age at diagnosis, clinical stage, and histological type, the HR for parous versus nulliparous women was 0.68 (95% confidence interval, 0.57-0.82). The prognostic impact of parity was restricted to patients with endometrioid tumors (P = 0.014, test for interaction) and appeared to be most pronounced in women without metastases (P = 0.14, test for interaction). Moreover, the improved prognosis was strongest for women with the shortest time interval since last childbirth. The HRs (nulliparous women as reference) were 0.51, 0.60, and 0.80 for women less than 15, 15 to 24, and 25 years or more since birth (P < 0.001). The observed beneficial effect of pregnancies may be related to a strong exposure to progesterone during pregnancy. However, it is possible that tumors developing in nulliparous and parous women have different biological features. Further knowledge on this issue may provide valuable information that can be used for individualized treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19509568     DOI: 10.1111/IGC.0b013e3181a3e1bf

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  3 in total

1.  Cervical stromal involvement can predict survival in advanced endometrial carcinoma: a review of 67 patients.

Authors:  Salih Taşkın; Fırat Ortaç; Korhan Kahraman; Göksu Göç; Derya Oztuna; Mete Güngör
Journal:  Int J Clin Oncol       Date:  2011-11-18       Impact factor: 3.402

2.  Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.

Authors:  Ashley S Felix; D Scott McMeekin; David Mutch; Joan L Walker; William T Creasman; David E Cohn; Shamshad Ali; Richard G Moore; Levi S Downs; Olga B Ioffe; Kay J Park; Mark E Sherman; Louise A Brinton
Journal:  Gynecol Oncol       Date:  2015-09-01       Impact factor: 5.482

3.  Long-term survival of endometrioid endometrial cancer patients.

Authors:  Leszek Gottwald; Piotr Pluta; Janusz Piekarski; Michał Spych; Katarzyna Hendzel; Katarzyna Topczewska-Tylinska; Dariusz Nejc; Robert Bibik; Jerzy Korczyński; Aleksandra Ciałkowska-Rysz
Journal:  Arch Med Sci       Date:  2010-12-29       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.